Please login to the form below

Webinar: How to develop an optimal value story for your product

This webinar is part of the ongoing expert insights series run by Valid Insight

Thursday 30th July at 2pm BST / 9am EST

Register now.

Developing a compelling, differentiated, value proposition is crucial for optimal market access. With input from a panel of experts, Raf De Wilde, our Senior Executive Advisor, and Carolyn Steeds, Associate Director, will discuss how to develop a successful payer value strategy while avoiding some of the common pitfalls that experience tells can hinder pricing and market access success.

Expert panelists: 
  • Marcus Dahlman, European Head of Market Access at Hansa Biopharma.
  • Brent Fraser, Vice President of CADTH, Pharmaceutical Reviews.
  • Harry Ward, Former director of Commissioning to Wolverhampton City Primary Care Trust

Register here.

24th July 2020



Company Details

Valid Insight

+44 (0) 20 3750 9833

Contact Website

152-160 City Road
Kemp House
United Kingdom

Latest content on this profile

Webinar: How to develop an optimal value story for your product
This webinar is part of the ongoing expert insights series run by Valid Insight
Valid Insight
Last chance to register - Webinar: How to price a pharmaceutical product during a global economic recession
How can you ensure your product achieves optimal market access during a global economic recession?
Valid Insight
Are biobetters a market access opportunity?
Biobetters are biologics that have been improved compared to the marketed originator, for example in efficacy, safety, tolerability or dosing regimen.
Valid Insight
Why are new medicinal products denied reimbursement in France?
Many medicinal products looking to launch are rejected for reimbursement in France. A manufacturer must convince the Transparency Committee that their product is safe, effective and offers added value relative to alternative treatments for successful market access. In this blog, we summarise the reasons for negative reimbursement decisions in 2017 and discuss common pitfalls manufacturers should avoid.
Valid Insight
Using TRAVELLESS™ to provide tailored pharmaceutical training
In May 2020, Valid Insight were scheduled to travel to Grenoble to deliver the market access modules as part of the Advanced Master’s in Biotechnology & Pharmaceutical Management programme with Grenoble Ecole de Management, a French graduate business school. The course has participants from varied backgrounds, but all from roles within the pharmaceutical industry.
Valid Insight
The vicious circle of pharmaceutical tendering
Pharmaceutical tendering and contracting has long been common in healthcare for medical devices and diagnostics; the Gulf Cooperation Council and the Jamaica Commodity Trading Company have been using pharmaceutical tendering since the 1970s. In the 1990s, international institutions such as the World Health Organisation and the World Bank endorsed tendering as the preferred procurement process for drugs.
Valid Insight